ARCHIVES

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 9 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.

November 30, 2001

Bushes Restate Commitment to Dialogue

August 8, 2003

Freestanding Cancer Centers May Be The “Missing Ingredient In Cancer Treatment,” DeVita Believes

January 11, 1985

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993

Frozen Section Analysis Helps Avoid Second Surgery

September 30, 2005

Rauscher Decision Put Off To July 1: Administration Backs Pay Raise Bill

June 25, 1976